---
agency: Department of Health and Human Services
applicant_types:
- Federal
- Government - General
- Individual/Family
- Interstate
- Local (includes State-designated Indian Tribes, excludes institutions of higher
  education and hospitals
- Minority group
- Non-Government - General
- Profit organization
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Specialized group (e.g. health professionals, students, veterans)
- Sponsored organization
- State
- State (includes District of Columbia, public institutions of higher education and
  hospitals)
- U.S. Territories and possessions
- U.S. Territories and possessions (includes institutions of higher education and
  hospitals)
assistance_types:
- Project Grants
authorizations:
- text: Pub. L. The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria
    Act of 2003; The Tom Lantos and Henry J. Hyde United States Global Leadership
    Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Public
    Law 108-25; Public Law 110-293. Title 42 [42 USC] U.S.C. &sect; Section 307 [42
    USC 242l], as amended and Section 301(a) [42 USC 241(a)], as amended.
  url: null
beneficiary_types:
- Anyone/general public
- Artist/Humanist
- Education Professional
- Federal
- Graduate Student
- Health Professional
- Individual/Family
- Interstate
- Local
- Minority group
- Other private institution/organization
- Private nonprofit institution/organization
- Profit organization
- Quasi-public nonprofit organization
- Scientist/Researchers
- Small business
- Specialized group (e.g. health professionals, students, veterans)
- Sponsored organization
- State
- Student/Trainee
- U.S. Territories
categories:
- Education - Health Education and Training
cfda: '93.494'
fiscal_year: '2024'
grants_url: https://grants.gov/search-grants?cfda=93.494
improper_payments: null
is_subpart_f: 1
layout: program
objective: 'CDCâ€™s global health priorities include efforts towards ending the global
  tuberculosis (TB) epidemic by:  expanding access to improved screening, contact
  tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing treatment
  for TB and multi-drug-resistant (MDR) TB, including identifying and evaluating better
  treatment regimens, and expanding access to care and treatment (CURE); breaking
  the cycle of TB transmission by strengthening infection control, identifying TB
  hotspots to target screening, and scaling-up treatment to prevent TB (PREVENT);
  and helping countries strengthen their surveillance and laboratory systems, and
  workforce and research capacity to support sustainable health systems including
  promoting the wider use and adoption of recommended TB strategies and guidelines
  (SUSTAIN).'
obligations: '[{"x":"2023","sam_estimate":0.0,"sam_actual":2724866.0,"usa_spending_actual":2724866.0},{"x":"2024","sam_estimate":0.0,"sam_actual":6489420.0,"usa_spending_actual":6864420.0},{"x":"2025","sam_estimate":0.0,"sam_actual":4950000.0,"usa_spending_actual":119679.0}]'
other_program_spending: null
outlays: '[{"x":"2023","outlay":1423116.06,"obligation":3396215.0},{"x":"2024","outlay":41742045.69,"obligation":2925000.0},{"x":"2025","outlay":57795533.04,"obligation":119679.0}]'
permalink: /program/93.494.html
popular_name: ''
program_type: assistance_listing
results: []
rules_regulations: Recipients  must comply with the administrative and public policy
  requirements outlined in 45 CFR Part 75 and the HHS Grants Policy Statement, as
  appropriate.
sam_url: https://sam.gov/fal/3c7183d7118b48a382f1c5719bfa8ae2/view
sub-agency: Centers for Disease Control and Prevention
title: Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative
  Approaches to Find, Cure, and Prevent Tuberculosis Globally
usaspending_url: https://www.usaspending.gov/search/?hash=ccb94cf500f559a085865cea24062b84
---
